Journal
NEUROSCIENCE RESEARCH
Volume 75, Issue 3, Pages 204-209Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.neures.2013.01.006
Keywords
Notch; RBP-J; Ischemia, Reactive astrocytes; Olig2
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology (MEXT) [20790244, 23790350]
- RIKEN Biorisource Center (RIKEN BRC)
- Grants-in-Aid for Scientific Research [24659143, 23790350, 20790244] Funding Source: KAKEN
Ask authors/readers for more resources
Treatment with DAPT, an inhibitor of the Notch-activating enzyme, gamma-secretase is known to reduce damage to ischemic brain. However, the molecular mechanisms supporting this therapeutic effect are not fully understood. Here we demonstrated that Notch/RBP-J signaling is activated in NG2(+) glial progenitors and reactive astrocytes such as GFAP(+) cells, Nestin(+) cells and RC2(+) cells, using Notch/RBP-J signaling reporter mice. 3-day DAPT treatment reduced the number of reactive astrocytes but not NG2(+) glial progenitors. BrdU labeling experiments have shown that this reduction was due to decreased proliferation of reactive astrocytes. DAPT inhibited nuclear-translocation of Olig2, which is indispensable for proliferation and differentiation of reactive astrocytes. These findings suggest that Notch signaling might promote proliferation and differentiation of reactive astrocytes through the regulation of nucleo-cytoplasmic translocation of Olig2. (C) 2013 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available